These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
187 related items for PubMed ID: 26055415
1. How to best measure the effectiveness of male human papillomavirus vaccine programmes? Garland SM, Molesworth EG, Machalek DA, Cornall AM, Tabrizi SN. Clin Microbiol Infect; 2015 Sep; 21(9):834-41. PubMed ID: 26055415 [Abstract] [Full Text] [Related]
6. Quadrivalent human papillomavirus vaccination and trends in genital warts in Australia: analysis of national sentinel surveillance data. Donovan B, Franklin N, Guy R, Grulich AE, Regan DG, Ali H, Wand H, Fairley CK. Lancet Infect Dis; 2011 Jan; 11(1):39-44. PubMed ID: 21067976 [Abstract] [Full Text] [Related]
9. Modeling preventative strategies against human papillomavirus-related disease in developed countries. Canfell K, Chesson H, Kulasingam SL, Berkhof J, Diaz M, Kim JJ. Vaccine; 2012 Nov 20; 30 Suppl 5(0 5):F157-67. PubMed ID: 23199959 [Abstract] [Full Text] [Related]
10. 9-Valent HPV vaccine for cancers, pre-cancers and genital warts related to HPV. Pitisuttithum P, Velicer C, Luxembourg A. Expert Rev Vaccines; 2015 Nov 20; 14(11):1405-19. PubMed ID: 26366475 [Abstract] [Full Text] [Related]
11. Evaluating the Early Benefit of Quadrivalent HPV Vaccine on Genital Warts in Belgium: A Cohort Study. Dominiak-Felden G, Gobbo C, Simondon F. PLoS One; 2015 Nov 20; 10(7):e0132404. PubMed ID: 26147096 [Abstract] [Full Text] [Related]
13. Monitoring the impact of HPV vaccine in males-Considerations and challenges. Brotherton JML, Giuliano AR, Markowitz LE, Dunne EF, Ogilvie GS. Papillomavirus Res; 2016 Dec 20; 2():106-111. PubMed ID: 29074169 [Abstract] [Full Text] [Related]
14. Near elimination of genital warts in Australia predicted with extension of human papillomavirus vaccination to males. Korostil IA, Ali H, Guy RJ, Donovan B, Law MG, Regan DG. Sex Transm Dis; 2013 Nov 20; 40(11):833-5. PubMed ID: 24113401 [Abstract] [Full Text] [Related]
15. Measuring human papillomavirus (HPV) vaccination coverage and the role of the National HPV Vaccination Program Register, Australia. Gertig DM, Brotherton JM, Saville M. Sex Health; 2011 Jun 20; 8(2):171-8. PubMed ID: 21592430 [Abstract] [Full Text] [Related]
16. The prophylactic role for the human papillomavirus quadrivalent vaccine in males. Yancey AM, Pitlick JM, Forinash AB. Ann Pharmacother; 2010 Jun 20; 44(7-8):1314-8. PubMed ID: 20501891 [Abstract] [Full Text] [Related]
17. Impact of Number of Human Papillomavirus Vaccine Doses on Genital Warts Diagnoses Among a National Cohort of U.S. Adolescents. Perkins RB, Lin M, Wallington SF, Hanchate A. Sex Transm Dis; 2017 Jun 20; 44(6):365-370. PubMed ID: 28499288 [Abstract] [Full Text] [Related]
18. Incremental impact of adding boys to current human papillomavirus vaccination programs: role of herd immunity. Brisson M, van de Velde N, Franco EL, Drolet M, Boily MC. J Infect Dis; 2011 Aug 01; 204(3):372-6. PubMed ID: 21742835 [Abstract] [Full Text] [Related]
19. [The first vaccine against cancer: the human papillomavirus vaccine]. Bősze P. Orv Hetil; 2013 Apr 21; 154(16):603-18. PubMed ID: 23587540 [Abstract] [Full Text] [Related]
20. Post-licensure monitoring of HPV vaccine in the United States. Markowitz LE, Hariri S, Unger ER, Saraiya M, Datta SD, Dunne EF. Vaccine; 2010 Jul 05; 28(30):4731-7. PubMed ID: 20188681 [Abstract] [Full Text] [Related] Page: [Next] [New Search]